Developability and Candidate Selection  
Advances in Characterization Methods and Approaches  
Comparability and Biosimilarity  

CHI’s 7th Annual Biotherapeutics Analytical Summit (March 14-18, 2016 in Bethesda, MD) received positive feedback and great applause from the 200+ attendees and speakers who shared their invaluable experiences, unique case studies, and creative approaches to solving the analytical challenges they faced.

The week-long event featured 3 conference tracks, 2 training seminars, 3 short courses, 16 exhibit booths and 30 posters. One of the highlight’s of the Summit were the Breakout Roundtable Discussions, which brought the attendees together to discuss a variety of exciting topics from mitigation of immunogenicity risk to characterizing aggregation to ADC analytical challenges.

The Summit will be back in Bethesda next year. Mark your calendar to join us on March 20-24, 2017 at the Hyatt Regency in Bethesda, Maryland for the 8th AnnualBiotherapeutics Analytical Summit!

“The Summit was great! There was a diverse array of speakers from academia, industry and regulatory agencies, and the talks were very useful for my company”

- Scientist, Seattle Genetics

“Enjoyed having presentations from those in biopharma, industry and hearing practical, real-life applications of new characterization methods.”

- Senior Scientist, MedImmune

“Great talks from academia/university personnel with reviews of the literature.”

- Professor, University of Manitoba

“Very intimate setting; insightful presentations. A great way to get perspective of the field!”

- Scientist, Janssen

“Five-star meeting”

- Senior Scientist III, Abbvie Inc.

“Great meeting. Important/relevant topics. Highly recommended.”

- Principal Scientist, Novartis Pharma AG

“Very fruitful and efficient.”

- Principal Scientist, Janssen R&D

“It is a great intimate conference. I really enjoyed the science, social events and connecting with peers in the industry.”

- Senior Scientist, AbbVie

Register Now
Register Now
Register Now